Influenza News and Research

Latest Influenza News and Research

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Possible impact of spike protein mutations on SARS-CoV-2 Omicron variant

Possible impact of spike protein mutations on SARS-CoV-2 Omicron variant

Scientists identify molecular features of antibody responses to SARS-CoV-2 spike

Scientists identify molecular features of antibody responses to SARS-CoV-2 spike

Strict COVID anti-contagion policies can provide long-term health benefits

Strict COVID anti-contagion policies can provide long-term health benefits

New nanoparticle adjuvant could help make vaccines more powerful

New nanoparticle adjuvant could help make vaccines more powerful

Modeling emergence and dynamics of new COVID-19 variants in the UK

Modeling emergence and dynamics of new COVID-19 variants in the UK

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Novel approach to estimate transmission advantage of SARS-CoV-2 variants in real-time

Plant-derived virus-like particle vaccines against SARS-CoV-2

Plant-derived virus-like particle vaccines against SARS-CoV-2

Nanoengineers develop a new approach to effectively deliver mRNA into cells

Nanoengineers develop a new approach to effectively deliver mRNA into cells

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

Omicron and other coronavirus variants: What you need to know

Omicron and other coronavirus variants: What you need to know

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.